Funds and ETFs Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Pharmaceuticals

Delayed Bombay S.E. 09:28:06 09/05/2024 BST 5-day change 1st Jan Change
1,284 INR -0.95% Intraday chart for Caplin Point Laboratories Limited -3.56% -5.34%

ETFs positioned on Caplin Point Laboratories Limited

Name Weight AuM 1st Jan change Investor Rating
0.00% 0 M€ +3.22% -
Caplin Point Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in producing, developing, and marketing a range of generic formulations and branded products and exporting to overseas markets. Its products include tablets, dry syrups (bottles), soft gels, capsules, suppositories, liquid syrups (bottles), liquid injectables in ampoules and vials, lyophilized vials, prefilled syringes (PFS), emulsion injection in ampoules and vials, ophthalmic droppers, pre-mix bags, topicals and sachets (liquids and powders). It also manufactures a range of ointments, creams, gels and lotions. Its principal research and development facilities are in Tamil Nadu, India. Its principal manufacturing facility is in Puducherry, India. It has presence in Latin America (LATAM), Southern Africa and Francophone Africa along with a presence in United States of America and European region. The Company’s subsidiaries include Caplin Point Far East Limited and Caplin Steriles Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,296 INR
Average target price
1,579 INR
Spread / Average Target
+21.85%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CAPLIPOINT Stock
  4. Funds and ETFs Caplin Point Laboratories Limited